Capital Impact Advisors, LLC Aclaris Therapeutics, Inc. Transaction History

Capital Impact Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$2.13 - $7.06 $403,500 - $1.34 Million	-189,437 Closed	0 $0
Q4 2018 Mar 08, 2019	BUY	$6.3 - $15.4 $608,252 - $1.49 Million	96,548 Added 103.94%	189,437 $1.39 Million
Q3 2018 Oct 19, 2018	BUY	$14.38 - $20.89 $64,321 - $93,440	4,473 Added 5.06%	92,889 $1.39 Million
Q2 2018 Jul 25, 2018	BUY	$16.46 - $20.33 $317,826 - $392,551	19,309 Added 27.94%	88,416 $1.69 Million
Q1 2018 Apr 11, 2018	BUY	$17.08 - $25.64 $375,435 - $563,592	21,981 Added 46.64%	69,107 $1.21 Million
Q3 2017 Jan 16, 2018	BUY	$23.02 - $28.8 $1.08 Million - $1.36 Million	47,126	47,126 $1.22 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.